Evidence map›Paper›PMID 41019458›Full record

ArticleNature machine intelligence2025

Conditional generation of real antigen-specific T cell receptor sequences.

Dhuvarakesh Karthikeyan, Sarah N Bennett, Amy G Reynolds, Benjamin G Vincent, Alex Rubinsteyn

Abstract read
In one paragraph

Article in Nature machine intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. AMULETY: A Python package to embed adaptive immune receptor sequences.Immunoinformatics (Amsterdam, Netherlands) · 2026
    Article
  7. Therapeutic application of IL-12 for cancer therapy.Translational cancer research · 2026
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dhuvarakesh KarthikeyanPersonalized Immunotherapy Research Lab, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.ORCID 0000-0001-5819-7561
Sarah N BennettPersonalized Immunotherapy Research Lab, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.ORCID 0000-0002-4605-2776
Amy G ReynoldsDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, Chapel Hill, NC USA.ORCID 0009-0000-2935-1750
Benjamin G VincentPersonalized Immunotherapy Research Lab, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.
Alex RubinsteynPersonalized Immunotherapy Research Lab, University of North Carolina at Chapel Hill, Chapel Hill, NC USA.ORCID 0000-0003-2839-2870

Funding

Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation.R37CA247676 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VINCENT, BENJAMIN G · 2020 to 2025
$3.6M
NCI NIH HHS R37 CA247676
6 · The paper itself

Abstract

Despite recent advances in T cell receptor (TCR) engineering, designing functional TCRs against arbitrary targets remains challenging due to complex rules governing cross-reactivity and limited paired data. Here we present TCR-TRANSLATE, a sequence-to-sequence framework that adapts low-resource machine translation techniques to generate antigen-specific TCR sequences against unseen epitopes. By evaluating 12 model variants of the BART and T5 model architectures, we identified key factors affecting performance and utility, revealing discordances between these objectives. Our flagship model, TCRT5, outperforms existing approaches on computational benchmarks, prioritizing functionally relevant sequences at higher ranks. Most significantly, we experimentally validated a computationally designed TCR against Wilms' tumour antigen, a therapeutically relevant target in leukaemia, excluded from our training and validation sets. Although the identified TCR shows cross-reactivity with pathogen-derived peptides, highlighting limitations in specificity, our work represents the successful computational design of a functional TCR construct against a non-viral epitope from the target sequence alone. Our findings establish a foundation for computational TCR design and reveal current limitations in data availability and methodology, providing a framework for accelerating personalized immunotherapy by reducing the search space for novel targets.

Indexed as

Adaptive immunityMachine learning

Identifiers

PMID41019458
PMCPMC12460172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.